Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

The authors conclude that early use of semaglutide may serve as an effective adjunctive strategy to mitigate the metabolic burden associated with SGAs. By intervening during the initial stages of ...

June 4, 2009 — The latest results from the European First Episode Schizophrenia Trial (EUFEST) show that when it comes to improving cognition in patients with schizophrenia, there is little difference ...

SCOTTSDALE, Arizona ― Second-generation antipsychotics (SGAs) differ with regard to efficacy and side effect profiles for the treatment of first-episode psychosis, according to the results of a new ...

Second-generation antipsychotics like aripiprazole, risperidone and quetiapine are often effective in treating mood disorder, ...

Schizophrenia medication falls under two main categories: older, first-generation, or "typical" antipsychotics and newer drugs for schizophrenia known as second-generation or "atypical" antipsychotics ...

They are more likely to die from disease. They are more likely to die from violence. They are more likely to die as they age. And they don’t live nearly as long. The life expectancy of people with ...

First-generation antipsychotics (typical antipsychotics) were the first antipsychotics developed and are not as commonly used because they have more side effects than second-generation antipsychotics.

Second-Generation Antipsychotic Drugs This table lists the atypical antipsychotics. For a story on the lessons of the CATIE trial, click here. For a table of first-generation drugs, click here. For a ...

Since the first antipsychotic medication, chlorpromazine, was developed in the early 1950s, it could be argued that not all that much has changed in the pharmacological treatment of psychotic ...

NEW YORK (Reuters Health) - People who take newer drugs for schizophrenia and other psychotic conditions are supposed to have their blood sugar and cholesterol levels checked regularly but many don't, ...

Teva announces positive real-world outcomes for UZEDY® and TEV-'749 in schizophrenia treatment, highlighting improved adherence and reduced hospital visits. Teva Pharmaceuticals has announced positive ...